|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4184 | (2006.01) |
| A61K 31/454 | (2006.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61P 9/10 | (2006.01) |
| (11) | Number of the document | 2420234 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11189346.7 |
| Date of filing the European patent application | 2006-04-11 | |
| (97) | Date of publication of the European application | 2012-02-22 |
| (45) | Date of publication and mention of the grant of the patent | 2013-07-10 |
| (46) | Date of publication of the claims translation | 2013-10-25 |
| (30) | Number | Date | Country code |
| 670204 P | 2005-04-11 | US |
| (72) |
Zhu, Guidong, US
Gong, Jianchun, US
Gandhi, Virajkumar, B., US
Penning, Thomas, D., US
Giranda, Vincent, US
|
| (73) |
AbbVie Ireland Unlimited Company,
c/o Codan Services Limited, Clarendon House, 2 Church Street, HM11 Hamilton,
BM
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 1H-benzimidazol-4-karboksamidai, 2 padėtyje pakeisti ketvirtine anglimi, kaip PARP inhibitoriai, skirti panaudoti vėžio gydymui |
| 1H-BENZIMIDAZOLE-4-CARBOXAMIDES SUBSTITUTED WITH A QUATERNARY CARBON AT THE 2-POSITION AS PARP INHIBITORS FOR USE IN TREATING CANCER |
| Payment date | Validity (years) | Amount | |
| 2024-03-18 | 19 | 347.00 EUR |
| 2025-04-11 |